Trade Gilead GILD

Sell
 Buy

Gilead live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Ava Grace 2025 Nov 08, 00:00

AI Funding Concerns Trigger Tech Stock Sell-Off

Sophia Claire 2025 Nov 08, 00:00

Gold Price Outlook: Currency Devaluation Trade Still Alive

Liam James 2025 Nov 08, 00:00

JPMorgan Sees Buying Opportunity Amid Market Jitters

Emma Rose 2025 Nov 07, 00:00

The Fed's Balance Sheet Expansion: Drivers and Potential Implications

Noah Lee 2025 Nov 07, 00:00

LME Aluminum Bull Run: Is a Structural Deficit Emerging?

Frances Wang 2025 Nov 06, 16:00

Gold and silver prices are up: what's happening to Gold (XAU/USD) and XAG?

Frances Wang 2025 Nov 06, 16:00

Nvidia Competitors Analysis (2026), NVDA Stock: AMD, Intel, Qualcomm, AVGO

Frances Wang 2025 Nov 05, 16:00

Crypto market update: Ethereum price drops, Bitcoin price falls below $104K

Frances Wang 2025 Nov 05, 16:00

XRP price prediction: XRP rebounds, Is XRP expected to go high?

Frances Wang 2025 Nov 05, 16:00

Tesla stock jumps 4% today: what’s driving the TSLA share price?

Latest news

Show more
Emma Rose 2025 Nov 09, 01:40

DeFi's Natural Selection: Lessons from Stream Finance & Aave's Resilience

Emma Rose 2025 Nov 09, 01:40

Bitcoin Dominance Fluctuations: A Harbinger of Altcoin Season?

Ava Grace 2025 Nov 09, 00:30

NFT Market Weekly Report: Trading Volume and User Engagement Decline

Noah Lee 2025 Nov 09, 00:10

XRP's Misunderstood Potential: Building a Global Financial Infrastructure

Emma Rose 2025 Nov 08, 23:10

Bitcoin Power Law Suggests Potential Surge to $142,000 Amidst Analyst Revisions

Ava Grace 2025 Nov 08, 21:10

Ex-Binance CEO CZ Expresses Surprise at Trump Pardon, Denies Business Ties

Sophia Claire 2025 Nov 08, 19:00

The Eroding Nation-State: How Blockchain Challenges Traditional Governance

Sophia Claire 2025 Nov 08, 13:10

Pakistan Considers Rupee-Backed Stablecoin Amid Crypto Regulation Delays

Info

Spread

0.75

Spread (%)

0.6329 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

153262800896

Shares Outstanding

1242000000

Earnings Date (Next)

2013-01-28

Div Yield

2025-12-30

Ex-Dividend Date

2025-12-15

Forward annual dividend rate

3.16

Forward annual dividend yield

0.0256

EPS

6.47

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 06, 16:00

How to start cryptocurrency trading: how to trade BTC Price (BTC/USD) CFDs?

Ghko B 2025 Nov 06, 16:00

Xom Stock Forecast: What is the future forecast for XOM?

Ghko B 2025 Nov 06, 16:00

Top Australian Shares: Argo Investments, BHP, CBA stock and more

Trustpilot